Previous 10 | Next 10 |
2023-05-19 08:20:29 ET Lucy Scientific Discovery ( LSDI ) +43% . Farfetch Limited ( FTCH ) +22% Q1 earnings call release Greenland Technologies Holding ( GTEC ) +14% Q1 earnings call release Nabriva Therapeutics ( NBRV ) +11% . G...
2023-05-17 12:56:05 ET Gainers: Immutep Limited ( IMMP ) +114% . WeTrade Group ( WETG ) +56% . Smart for Life ( SMFL ) +56% . National Western Life Group ( NWLI ) +40% . Bausch Health Companies ( BHC ) +37% . SelectQuote ( ...
2023-05-02 19:28:09 ET Rigel Pharmaceuticals, Inc. (RIGL) Q1 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Ray Furey - EVP, General Counsel and Corporate Secretary. Raul Rodriguez - President and CEO Dave Santos - EVP and Chief Commerc...
2023-05-02 16:32:21 ET Rigel Pharmaceuticals press release ( NASDAQ: RIGL ): Q1 GAAP EPS of -$0.08 beats by $0.02 . Revenue of $26.07M (+55.7% Y/Y) beats by $2M . For further details see: Rigel Pharmaceuticals GAAP EPS of -$0.08 beats by $0.02, revenue of...
Rigel Reports First Quarter 2023 Financial Results and Provides Business Update PR Newswire First quarter 2023 Total Revenue of $26.1 million which includes TAVALISSE ® net product sales of $22.3 million and REZLIDHIA ® net product sales of $1.5 m...
2023-04-27 03:27:22 ET Summary RIGL is set to report Q1'23 earnings on Tuesday, May 2, with the stock currently trading around year-to-date lows. RIGL is a two drug company nowadays, with the recent approval and launch of Rezlidhia, but Tavalisse is still a major story and Q1'23 e...
Rigel Announces Conference Call and Webcast to Report First Quarter 2023 Financial Results and Business Update PR Newswire SOUTH SAN FRANCISCO, Calif. , April 25, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will re...
2023-04-03 15:46:46 ET Piper Sandler has initiated Rigel Pharmaceuticals with a hold rating saying that while a recent downsizing and in-licensing of a leukemia drug are positives, more visibility is needed on the road to profitability. The firm has a $2 price target (~52% upside ...
2023-03-09 08:45:20 ET Silvergate Capital SI -36% on plans to wind down operations, liquidate Silvergate Bank . SVB Financial SIVB -28% on $1.25B stock offering, $500M depositary share offering . Arhaus ARHS -11% on Q4 earnings release . Altamira Th...
2023-03-09 05:59:46 ET Summary Rigel Pharma has 2 FDA-approved drugs: Tavalisse for chronic immune thrombocytopenia (ITP) and Rezlidhia for relapsed or refractory AML with susceptible IDH1 mutation. In Q4 2022, Tavalisse revenue slightly rose, yet its utilization in ITP remains re...
News, Short Squeeze, Breakout and More Instantly...
Rigel Pharmaceuticals Inc. Company Name:
RIGL Stock Symbol:
NASDAQ Market:
Rigel Pharmaceuticals Inc. Website:
2024-06-27 09:02:05 ET Rigel Pharmaceuticals (RIGL) announced stock split at a ratio of 1-for-10 on 2024-06-27 ... Full story available on KlickAnalytics.com
Rigel Announces Reverse Stock Split PR Newswire SOUTH SAN FRANCISCO, Calif. , June 25, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will effect a reverse stock split of its issued and outstanding shares of common st...
Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application PR Newswire GAVRETO will be available from Rigel in the U.S. beginning June 27, 2024 SOUTH SAN FRANCISCO, Calif. , June 24, 2024 /PRNewswire/ -- Rigel Pharmac...